SUCCESS STORY
Increase in Treatment Volume
Improvement in Cost Per Lead
NeuroStar was already leading the category—but in a category few truly understood. With a precision digital strategy approach and trust-first messaging, we didn’t just grow NeuroStar’s brand—we helped elevate TMS therapy itself. What started as a challenge to educate became an opportunity to reframe the treatment, reset expectations, and drive measurable growth at scale.
Breaking Barriers to Mental Health Access
Repositioning NeuroStar’s FDA-cleared TMS therapy meant more than visibility—it required reshaping perceptions of the therapy and building trust in a treatment often seen as a last resort. The campaign had to overcome three interconnected challenges:
Misunderstood Technology in a Growing Category
Low Awareness and Uneven Provider Buy-In
Complex Buyer Journeys with High Emotional and Clinical Stakes
As the category leader, NeuroStar carried both an opportunity and a responsibility: to help more patients access an effective treatment—and in doing so, expand awareness for the entire TMS category.
Digital-First Strategy Built Around Real Behavior
We architected a media journey tailored to how patients research and act, deploying platform-native content across paid search, CTV, online video, and programmatic media.
Persona-Driven Messaging That Converted Skeptics
Using first- and third-party data, we built behavioral personas like The Researcher and The Skeptic, tailoring messaging, media mix, and frequency to their readiness stage.
Full-Funnel Activation Around One Clear Goal
Every tactic—whether upper-funnel video or mid-funnel social—was engineered to drive users toward one frictionless action: booking an appointment via the “Find a Provider” tool.
Provider Messaging Backed by ROI and Demand Signals
We didn’t stop at the patient. Custom campaigns targeted clinics with proof of patient volume, practice ROI, and real-world demand, driving earlier consideration and provider adoption.
